JP2005518439A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518439A5
JP2005518439A5 JP2003570882A JP2003570882A JP2005518439A5 JP 2005518439 A5 JP2005518439 A5 JP 2005518439A5 JP 2003570882 A JP2003570882 A JP 2003570882A JP 2003570882 A JP2003570882 A JP 2003570882A JP 2005518439 A5 JP2005518439 A5 JP 2005518439A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
hydrogen
migraine
linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003570882A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518439A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/005463 external-priority patent/WO2003072138A1/en
Publication of JP2005518439A publication Critical patent/JP2005518439A/ja
Publication of JP2005518439A5 publication Critical patent/JP2005518439A5/ja
Pending legal-status Critical Current

Links

JP2003570882A 2002-02-26 2003-02-25 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬 Pending JP2005518439A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35989402P 2002-02-26 2002-02-26
PCT/US2003/005463 WO2003072138A1 (en) 2002-02-26 2003-02-25 Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents

Publications (2)

Publication Number Publication Date
JP2005518439A JP2005518439A (ja) 2005-06-23
JP2005518439A5 true JP2005518439A5 (https=) 2006-04-06

Family

ID=27663315

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003570882A Pending JP2005518439A (ja) 2002-02-26 2003-02-25 抗痙攣性誘導体と抗片頭痛薬を含んで成る片頭痛治療用共治療薬

Country Status (18)

Country Link
US (2) US20030225002A1 (https=)
EP (1) EP1478400A1 (https=)
JP (1) JP2005518439A (https=)
KR (1) KR101008326B1 (https=)
CN (1) CN100352506C (https=)
AU (1) AU2003213242A1 (https=)
BR (1) BR0307951A (https=)
CA (1) CA2419989A1 (https=)
HR (1) HRP20040846A2 (https=)
IL (2) IL163720A0 (https=)
MX (1) MXPA04008259A (https=)
NO (1) NO20043984L (https=)
NZ (1) NZ534874A (https=)
PL (1) PL372393A1 (https=)
RU (1) RU2004126093A (https=)
UA (1) UA81110C2 (https=)
WO (1) WO2003072138A1 (https=)
ZA (1) ZA200407729B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
WO2005079787A1 (en) * 2004-02-17 2005-09-01 Sepracor Inc. Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
CN101472644B (zh) * 2006-04-13 2014-04-23 纽帕特公司 递送抗偏头痛化合物的透皮方法和系统
WO2007127207A2 (en) * 2006-04-25 2007-11-08 Proethic Pharmaceuticals, Inc. Fixed combination dosage forms for the treatment of migraine
WO2008027557A2 (en) 2006-08-31 2008-03-06 Spherics, Inc. Topiramate compositions and methods of enhancing its bioavailability
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
ES2555066T3 (es) 2006-11-17 2015-12-28 Supernus Pharmaceuticals, Inc. Formulaciones de liberación sostenida de topiramato
ES2645719T3 (es) * 2006-12-04 2017-12-07 Supernus Pharmaceuticals, Inc. Formulaciones de topiramato de liberación inmediata mejoradas
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
ES2620672T3 (es) 2008-01-09 2017-06-29 Charleston Laboratories, Inc. Comprimidos de doble capa que comprenden oxicodona y prometazina
EP2331100B1 (en) * 2008-09-17 2014-07-16 The McLean Hospital Corporation Methods and kits for treating cluster headache disorders
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
CA3039169A1 (en) * 2016-10-06 2018-04-12 Baylor College Of Medicine Photochromatic modulation with fluorescein for the treatment of photo-oculodynia and blepharospasm
JP7476229B2 (ja) * 2019-04-15 2024-04-30 フェリン・ファーマシューティカルズ・インコーポレイテッド 片頭痛の治療

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
CA2264182A1 (en) * 1996-08-23 1998-02-26 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20020015713A1 (en) * 1996-10-24 2002-02-07 Murdock Robert W. Methods and transdermal compositions for pain relief
AU1930897A (en) * 1997-03-03 1998-09-22 Laboratoires Remilea Plant extract compositions, method of preparation, and pharmaceutical comp ositions containing them
US5855907A (en) * 1997-03-24 1999-01-05 Peyman; Gholam A. Method of treatment of migraine
US5935933A (en) * 1997-07-16 1999-08-10 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating neuropathic pain
US5760007A (en) * 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain
GB9720270D0 (en) * 1997-09-25 1997-11-26 Pharmagene Lab Limited Medicaments for the treatment of migraine
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
ES2228465T3 (es) * 1999-01-19 2005-04-16 Ortho-Mcneil Pharmaceutical, Inc. Uso derivados anticonvulsionantes para el tratamiento de cefaleas en brotes.
HUP0203198A3 (en) * 1999-08-20 2005-07-28 Ortho Mcneil Pharm Inc Pharmaceutical composition comprising a tramadol material and an anticonvulsant drug, process for its preparation and its use

Similar Documents

Publication Publication Date Title
JP2005518439A5 (https=)
RU2004126093A (ru) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
AR061584A1 (es) Uso de 2-aminotetralinas sustituidas para la fabricacion de un medicamento para la prevencion, alivio y/o tratamiento de diversos tipos de dolor
CR7510A (es) DERIVADOS DE [1-4] DIAZEPINO[6,7,1-iJ)] QUINOLONA COMO AGENTES ANTIPSICOTICOS Y CONTRA LA OBESIDAD
RU93033485A (ru) Производные индола, фармацевтическая композиция, способ лечения
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
IS7891A (is) Skiptitengd þrísýklísk gamma-karbólín sem serótónín viðtaka gerandefni og mótverkunarefni
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
NO20062139L (no) Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister
HUP0302167A2 (hu) Metabotropikus glutamát receptor antagonista hatású kinolinszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
JP2012521428A5 (https=)
JP2002523506A5 (https=)
JP2005512965A5 (https=)
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2004529114A5 (https=)
JP2004510813A5 (https=)
AU2003269923A8 (en) 2- (phenoxymethyl)- and 2- (phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitors
NO20065880L (no) 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor
MX2007006081A (es) Tetrahidroisoquinolinas 4-fenil-sustituidas y uso de las mismas para bloquear la recaptacion de norepinefrina, dopamina y serotonina.
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
JP2002529497A5 (https=)
JP2004533986A5 (https=)
EP1591441A4 (en) CARBON ACID COMPOUNDS
CA2523253A1 (en) Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
JP2002503724A5 (https=)